David Westenberg
Stock Analyst at Piper Sandler
(4.72)
# 135
Out of 5,090 analysts
188
Total ratings
61.68%
Success rate
29.25%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Overweight | $150 | $111.64 | +34.36% | 1 | Dec 1, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $15 → $19 | $17.78 | +6.86% | 3 | Nov 11, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $105 → $80 | $76.66 | +4.36% | 6 | Nov 11, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $1.5 → $2 | $2.39 | -16.32% | 10 | Nov 11, 2025 | |
| NTRA Natera | Maintains: Overweight | $220 → $230 | $244.55 | -5.95% | 17 | Nov 11, 2025 | |
| FLGT Fulgent Genetics | Maintains: Neutral | $21 → $30 | $27.74 | +8.15% | 10 | Nov 11, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $70 → $80 | $101.06 | -20.84% | 13 | Nov 11, 2025 | |
| CTKB Cytek Biosciences | Maintains: Overweight | $8 → $7.5 | $4.99 | +50.30% | 10 | Nov 11, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $200 | $182.51 | +9.58% | 8 | Oct 27, 2025 | |
| GH Guardant Health | Maintains: Overweight | $60 → $90 | $102.02 | -11.78% | 10 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 → $6.5 | $5.98 | +8.70% | 13 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $14.75 | +35.59% | 15 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $140 | $158.96 | -11.93% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $215 | $118.65 | +81.21% | 15 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $510 → $700 | $714.10 | -1.97% | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $18 | $21.90 | -17.81% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $11 | $11.90 | -7.56% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $185 | $128.99 | +43.42% | 16 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $260 → $280 | $258.39 | +8.36% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $27.76 | - | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $36.89 | - | 1 | Nov 21, 2017 |
BillionToOne
Dec 1, 2025
Initiates: Overweight
Price Target: $150
Current: $111.64
Upside: +34.36%
10x Genomics
Nov 11, 2025
Maintains: Neutral
Price Target: $15 → $19
Current: $17.78
Upside: +6.86%
Tempus AI
Nov 11, 2025
Maintains: Neutral
Price Target: $105 → $80
Current: $76.66
Upside: +4.36%
Pacific Biosciences of California
Nov 11, 2025
Maintains: Neutral
Price Target: $1.5 → $2
Current: $2.39
Upside: -16.32%
Natera
Nov 11, 2025
Maintains: Overweight
Price Target: $220 → $230
Current: $244.55
Upside: -5.95%
Fulgent Genetics
Nov 11, 2025
Maintains: Neutral
Price Target: $21 → $30
Current: $27.74
Upside: +8.15%
Exact Sciences
Nov 11, 2025
Maintains: Overweight
Price Target: $70 → $80
Current: $101.06
Upside: -20.84%
Cytek Biosciences
Nov 11, 2025
Maintains: Overweight
Price Target: $8 → $7.5
Current: $4.99
Upside: +50.30%
Quest Diagnostics
Oct 27, 2025
Maintains: Neutral
Price Target: $190 → $200
Current: $182.51
Upside: +9.58%
Guardant Health
Oct 22, 2025
Maintains: Overweight
Price Target: $60 → $90
Current: $102.02
Upside: -11.78%
Oct 16, 2025
Reiterates: Neutral
Price Target: $5 → $6.5
Current: $5.98
Upside: +8.70%
Oct 15, 2025
Maintains: Overweight
Price Target: $15 → $20
Current: $14.75
Upside: +35.59%
Sep 11, 2025
Maintains: Overweight
Price Target: $120 → $140
Current: $158.96
Upside: -11.93%
Aug 11, 2025
Maintains: Overweight
Price Target: $210 → $215
Current: $118.65
Upside: +81.21%
Aug 11, 2025
Maintains: Neutral
Price Target: $510 → $700
Current: $714.10
Upside: -1.97%
Aug 11, 2025
Maintains: Neutral
Price Target: $12 → $18
Current: $21.90
Upside: -17.81%
Aug 4, 2025
Maintains: Overweight
Price Target: $12 → $11
Current: $11.90
Upside: -7.56%
May 15, 2025
Maintains: Overweight
Price Target: $190 → $185
Current: $128.99
Upside: +43.42%
May 6, 2025
Maintains: Neutral
Price Target: $260 → $280
Current: $258.39
Upside: +8.36%
Jan 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $27.76
Upside: -
Nov 21, 2017
Initiates: Neutral
Price Target: n/a
Current: $36.89
Upside: -